Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flublok Quadrivalent in Children and Adolescents
NCT01959945Phase 3Completed
- Sponsor
- Protein Sciences
- Start
- Nov 2013
- Primary completion
- Jun 2014
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of influenza vaccine, recombinant hemagglutinin in influenza, sponsored by Protein Sciences. Started Nov 2013; status: completed.
02
Drugs
influenza vaccine, recombinant hemagglutinin
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01959945.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01959945.